{{Rsnum
|rsid=1558861
|Chromosome=11
|position=116736721
|Orientation=plus
|GMAF=0.118
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{GWAS Summary
|SNP=rs1558861
|PubMedID=18193046
|Condition=Triglycerides
|Gene=LOC440069, MGC13125
|Risk Allele=A
|pValue=2.00E-026
|OR=17
|95CI=13.28-20.72) % highe
}}

{{PharmGKB
|RSID=rs1558861
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18193046; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS Results: Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides (Initial Sample Size: 2,011 individuals; Replication Sample Size: 10,536 individuals; Risk Allele: rs1558861-A).
|Drugs=
|Drug Classes=
|Diseases=Cardiovascular Diseases; Coronary Disease
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356728
}}

{{PMID Auto GWAS
|PMID=20864672
|Trait=None
|Title=Genetic Variants Influencing Circulating Lipid Levels and Risk of Coronary Artery Disease
|RiskAllele=T
|Pval=0.000002
|OR=0.03
|ORtxt=[0.02-0.04] unit decrease
|OA=1
}}

{{ population diversity
| geno1 = (C;C)
| geno2 = (C;T)
| geno3 = (T;T)
| CEU | 0.0 | 8.3 | 91.7
| CHB | 0.0 | 46.7 | 53.3
| JPT | 4.4 | 44.4 | 51.1
| YRI | 0.0 | 0.0 | 100.0
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1558861
|overall_frequency_n=119
|overall_frequency_d=128
|overall_frequency=0.929688
|n_genomes=55
|n_genomes_annotated=0
|n_haplomes=99
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}